Cargando…

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma

Cutaneous squamous cell carcinoma (cSCC) of the head and neck region is the second most prevalent skin cancer, with metastases to regional lymph nodes occurring in 2%–5% of cases. To further our understanding of the molecular events characterizing cSCC invasion and metastasis, we conducted targeted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minaei, Elahe, Mueller, Simon A., Ashford, Bruce, Thind, Amarinder Singh, Mitchell, Jenny, Perry, Jay R., Genenger, Benjamin, Clark, Jonathan R., Gupta, Ruta, Ranson, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035872/ https://www.ncbi.nlm.nih.gov/pubmed/35480116 http://dx.doi.org/10.3389/fonc.2022.835929

Ejemplares similares

Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma
por: Thind, Amarinder Singh, et al.
Publicado: (2022)

Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities
por: Perry, Jay, et al.
Publicado: (2020)

Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
por: Yeo, Nicholas, et al.
Publicado: (2023)

A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
por: Genenger, Benjamin, et al.
Publicado: (2022)

Gene expression profiling of perineural invasion in head and neck cutaneous squamous cell carcinoma
por: Eviston, Timothy J., et al.
Publicado: (2021)

Protocol for the generation and automated confocal imaging of whole multi-cellular tumor spheroids
por: Genenger, Benjamin, et al.
Publicado: (2023)

Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study
por: Morosin, Tia, et al.
Publicado: (2016)

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
por: Kumar, Ashna A., et al.
Publicado: (2022)

Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity
por: Stillfried, Gillian E, et al.
Publicado: (2007)

Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia
por: Wilson, Anna, et al.
Publicado: (2022)

The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets
por: Buckley, Benjamin J., et al.
Publicado: (2019)

N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer
por: Belfiore, Lisa, et al.
Publicado: (2020)

Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx.
por: Parolini, S., et al.
Publicado: (1996)

The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis
por: Brungs, Daniel, et al.
Publicado: (2017)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

A Key Role for the Urokinase Plasminogen Activator (uPA) in Invasive Group A Streptococcal Infection
por: Sanderson-Smith, Martina L., et al.
Publicado: (2013)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
por: Tincknell, Gary, et al.
Publicado: (2021)

Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation
por: Cunningham, Orla, et al.
Publicado: (2009)

Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
por: Shanmukhappa, Kumar, et al.
Publicado: (2006)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
por: Baart, V. M., et al.
Publicado: (2020)

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
por: Sugioka, Koji, et al.
Publicado: (2012)

Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study
por: Bacchiocchi, Roberta, et al.
Publicado: (2008)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
por: Tucker, Torry A., et al.
Publicado: (2021)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry.
por: Kennedy, S., et al.
Publicado: (1998)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder
por: Dohn, Line H., et al.
Publicado: (2021)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_60rlf6o9lc5fbtpqqnlhfp2upv